Mucormycosis infection in severe COVID‐19 patient with multiple underlying health conditions
Abstract Patients with underlying health conditions are vulnerable to invasive fungal infection following COVID‐19. It seems that uncontrolled diabetes mellitus makes patients susceptible to both severe COVID‐19 and mucormycosis.
Enregistré dans:
Auteurs principaux: | Zahra Heydarifard, Moslem Safaei, Sevrin Zadheidar, Soroush Ehsan, Nazanin Zahra Shafiei‐Jandaghi |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Wiley
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/cb800dc93e534d55922e65f5b9af7166 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Vaccinated Patients Admitted in ICU with Severe Pneumonia Due to SARS-CoV-2: A Multicenter Pilot Study
par: Ángel Estella, et autres
Publié: (2021) -
Elevated Anti-SARS-CoV-2 Antibodies and IL-6, IL-8, MIP-1β, Early Predictors of Severe COVID-19
par: Helena Codina, et autres
Publié: (2021) -
Pulmonary Mucormycosis as the Leading Clinical Type of Mucormycosis in Western China
par: Junyan Qu, et autres
Publié: (2021) -
COVID-19 Clinical Profile in Latin American Migrants Living in Spain: Does the Geographical Origin Matter?
par: Abiu Sempere, et autres
Publié: (2021) -
A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19
par: Johanna Reinold, et autres
Publié: (2021)